To mark the BioMed Central conference Epigenetics & Chromatin: Interactions and processes that took place in Boston earlier this year, the open access journal Epigenetics & Chromatin has published a series of review articles that focus on addressing some of the biggest questions in epigenetics today.
The final review of the series, by Anton Wutz (ETH Zurich, Switzerland), has been published today, discussing how haploid genomes illustrate epigenetic constraints and gene dosage effects in mammals. In this review the authors, who have significantly advanced our understanding of haploidy in mammals, provide an insightful summary of systems available to study haploid genomes.
Other reviews in the series include a description of the role of the …
Two rarities seldom seen by Bostonians are the American Society of Human Genetics Annual Meeting (aka ASHG) and the baseball World Series. The former was last in Boston 60 years ago, in 1953 – the year of the double helix. The latter, a contest between grown men – as evidenced by a dazzling roster of beards – playing some sort of rounders derivative, has not been won on home turf by the city's Red Sox since 1918. But both events converged this year, with the geneticists of ASHG more than equal to the task of keeping all four bases covered. That is, the DNA bases A, C, G and T.
Mo' data, mo' solutions?
The most …
Our Storify continues with the 3rd and final day of COASP. The morning kicked off with Simon Thomson from Open Access Key.
View the story “Day 3 of 5th Conference on Open Access Scholarly Publishing ” on Storify
Day 1 – Day 2 – Day 3
On 10th-12th September 2013, Molecular Neurodegeneration, teamed with BioMed Central, held their third international conference in the beautifully sunny Cannes, France – Molecular Neurodegeneration: Basic biology and disease pathways. Attended by approximately 200 of both the top neurodegenerative researchers in the field and bright neuroscientists of the future, this meeting allowed for the sharing of the latest breakthrough findings as well as lively debates concerning where the future of this research area lies.
The expert organising committee of Guojun Bu, Robert Vassar, Huaxi Xu, Hui Zheng, Frédéric Checler and Henrietta M Nielsen assembled a high calibre of speakers that were divided into sessions to discuss the risk factors, pathology, mechanisms and therapy for a …
BioMed Central will be attending the IUNS 20th International Congress of Nutrition 2013 in Granada, Spain from 16-20th September, representing our open access nutrition journals.
At BioMed Central we are always keen to hear from our authors and readers, and we’d be delighted to meet you there. We would be especially interested in hearing your views on the BioMed Central portfolio of nutrition journals, including Nutrition Journal, Nutrition & Metabolism, and IJBNPA.
We will be blogging and tweeting from the conference. You can follow us on our global health Twitter account, @GHWindow, where we’ll be tweeting …
Accelerating the development of innovative treatments for Alzheimer’s disease and related dementias is the target for scientists brought together at the 14th International Conference on Alzheimer’s Drug Discovery, and the focus of a special thematic series in Alzheimer’s Research & Therapy.
Hosted by the Alzheimer’s Drug Discovery Foundation (ADDF), on 9 – 10 September 2013 in Jersey City, USA, academic and industry scientists will attend the annual conference to highlight scientific progress on drug discovery programs aimed at treating Alzheimer’s disease and related dementias, as well as forming partnerships with fellow researchers.
Early bird registration ends this Friday, 9th August – don’t miss out!
ADDF is a public charity supporting the advancement of drugs to prevent, treat, and cure Alzheimer’s …
The past two days have seen scientists, animal welfare officers, funding agencies and journal editors gather together in London for the 3rd Basel Declaration Society Conference. The focus? To discuss ways in which these various groups can collaborate to promote openness and transparency in animal research.
Following the Declaration of Helsinki, and its impact on human research, the Basel Declaration was adopted in 2010. The aim was to bring the scientific community together to further advance working and ethical practices whenever animals are used in research, and to call for more trust, transparency and communication on this sensitive topic.
Inspiring talks over the two days ranged from the need for honest communication and education about animal …
Based on transcripts from the 11th Congress in Evidence Based Perioperative Medicine (2012) presentations held in London, this recently launched article collection is a selection of the highlights from last July.
Evidence Based Perioperative Medicine (EBPOM.org) is a not for profit project with the key objective of supporting the assessment, discussion and application of evidence based medicine to perioperative care. The Congress in Evidence Based Perioperative Medicine is an annual 2-day meeting which provides a forum for research development, the practical acquisition of essential skills and dissemination of evidence based perioperative knowledge.
Editors-in-Chief, Monty Mythen and Mark Hamilton, co-chair the Evidence-Based Perioperative Medicine (EBPOM) series of conferences, along with several …
This year's Abcam conference on 'non-coding RNAs, epigenetics and transgenerational inheritance' had a distinct Lamarckian flavor with conference Chair and 2013 Hooke medal recipient, Eric Miska, recommending Arthur Koestler's 'The case of the midwife toad' as extracurricular reading. In addition to his literary recommendations Miska discussed his recently published observations on the ability of piRNA phenotypes to be inherited through generations in C. elegans. The nematode and RNAi theme was continued in Scott Kennedy's talk, which focused on his recently published work on identifying genes required for RNAi inheritance in C. elegans. He identified such genes through screening for mutants defective in transmitting RNAi phenotypes to the next generation, but which are still able …
It is not unusual per se for Nobel laureates to be quoted at genomics conferences, but it is perhaps a little out of the ordinary when the Nobel Prize in question is for Literature. But, then again, the Wellcome Trust's 'Genomic Disorders 2013: From 60 years of DNA to human genomes in the clinic' was not your run-of-the-mill conference; instead, a mesh of current research and historical (and futuristic) perspective paid tribute to the 60th anniversary of Watson and Crick's discovery of the double helix.
So it was not entirely out of keeping with expectations when philosopher (and former candidate for Slovene of the year) Renata Salecl stepped onto the podium and asked:
'Should I kill myself, or have …